ConductScience.org, home

Paper39159503

Glycyrrhizic acid alleviates concanavalin A-induced acute liver injury by regulating monocyte-derived macrophages.

Lu J and 10 others. Phytomedicine, 2024. Cited by 17 papers, by iCite.

Cite this record

ConductScience Library. Glycyrrhizic acid alleviates concanavalin A-induced acute liver injury by regulating monocyte-derived macrophages. Papers, record 39159503. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39159503

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Glycyrrhizic acid alleviates concanavalin A-induced acute liver injury by regulating monocyte-derived macrophages.
PubMed
Journal
Phytomedicine
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
2.74, provisional
iCite
Revised in PubMed
2024-08-30
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lu JJuan
2Gu XXinyu
3Xue CChen
4Shi QQingmiao
5Jia JJunjun
6Cheng JJinlin
7Zeng YYifan
8Chu QQingfei
9Yuan XXin
10Bao ZZhengyi
11Li LLanjuan

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Glycyrrhizic AcidMajor topic
Concanavalin AMajor topic
MacrophagesMajor topic
Chemical and Drug Induced Liver InjuryMajor topic
Animals
Mice
Hepatitis, Autoimmune
Mice, Inbred C57BL
Liver
Cytokines
Male
Anti-Inflammatory Agents

Source PubMed

Download CSV of topics

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
42965739Modulating the osteoimmune microenvironment: biomaterial strategies for bone regeneration and implant integration.Hum Cell2026https://conductscience.org/library/papers/42965739PubMed
42932011Integrated bulk and single-cell transcriptomics with virtual knockout analysis identifies FOS as an epithelial-associated candidate gene in chronic atrophic gastritis.Funct Integr Genomics2026https://conductscience.org/library/papers/42932011PubMed
42866300Glycyrrhizic acid attenuates sepsis-induced acute lung injury by regulating macrophage M2 polarization via PRKCD.J Thorac Dis2026https://conductscience.org/library/papers/42866300PubMed
42666651Spatial immune niche remodeling of the neutrophil-macrophage axis inchronic liver disease.Front Cell Dev Biol2026https://conductscience.org/library/papers/42666651PubMed
42477763Adoptive transfer of VSIG4+ macrophages interrupts the CCL2-CCR2 inflammatory amplification loop to mitigate acetaminophen-induced acute liver injury in murine and human organoid models.J Transl Med2026https://conductscience.org/library/papers/42477763PubMed
42396443Revealing the pathogenesis of autoimmune hepatitis and research progress in drug discovery from hepatic immune cells and intercellular communication signaling mechanisms.Front Immunol2026https://conductscience.org/library/papers/42396443PubMed
42307888Therapeutic potential of glycyrrhizic acid in inflammation-related diseases: from HMGB1-oriented molecular insights to preclinical application.Arch Pharm Res2026https://conductscience.org/library/papers/42307888PubMed
42298622Dietary glycyrrhizic acid improves growth performance and modulates upper respiratory microbiota in weaned piglets.BMC Vet Res2026https://conductscience.org/library/papers/42298622PubMed
42178778A multicentre randomized open-label phase 2 trial of dexamethasone plus glycyrrhizinate versus dexamethasone in newly diagnosed immune thrombocytopenia.Br J Haematol2026https://conductscience.org/library/papers/42178778PubMed
42147312Glycyrrhizin preparations in liver diseases: a narrative review of mechanisms and therapeutic potential.Front Pharmacol2026https://conductscience.org/library/papers/42147312PubMed
41307794Macrophage-derived exosomes in autoimmune diseases: mechanistic insights and therapeutic implications.Immunol Res2025https://conductscience.org/library/papers/41307794PubMed
41170366Development and preliminary mechanistic analysis of compound effervescent hepatoprotective granules.Front Nutr2025https://conductscience.org/library/papers/41170366PubMed
40696369Qu-zhuo-tong-bi decoction exerts gouty arthritis therapy by skewing macrophage polarization through butanoate metabolism.Chin Med2025https://conductscience.org/library/papers/40696369PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39159503

GET https://conductscience.org/api/papers/v1/39159503/authors